Dr Reddy's Laboratories informs about press release

16 Dec 2022 Evaluate
Dr Reddy's Laboratories has informed that Aurigene Oncology, a wholly owned subsidiary of Dr Reddy's Laboratories, reports results of AUR101 in Phase II Study in Patients with moderate to severe psoriasis. A press release in this regard is enclosed.

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Lab Share Price

1309.00 -9.90 (-0.75%)
27-Feb-2026 09:20 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1773.60
Dr. Reddys Lab 1309.00
Cipla 1343.55
Zydus Lifesciences 932.85
Lupin 2325.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×